Dr. Joseph E. Modrak, MD

Dr. Modrak practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Dr. Modrak's NPI, 1801820162, was assigned on July 10, 2006. Dr. Modrak holds New York license 188210.

Dr. Modrak's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Dr. Modrak's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Dr. Modrak to 6 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Modrak practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Modrak's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Modrak is licensed in New York.

CMS data shows 395 Medicare services from Dr. Modrak across 11 procedure codes in 2024, for 256 Medicare patients. Medicare paid $17,130 for them.

CMS counts 256 Medicare patients who saw Dr. Modrak in 2024. The largest group is 65 to 74, with 102 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Modrak's median patient age at 61, with 51% women.

In 2024, Dr. Modrak wrote 164 Medicare Part D claims for 44 patients. 69% of them were for generic drugs. CMS names the drug for 85 of them, across 6 drugs with 11 or more claims each, at $206,213 in total drug cost. In 2023, CMS named 39 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Modrak for performance year 2024, reported as part of a group. Dr. Modrak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Modrak as offering telehealth.

Dmand AI links 3 papers to Dr. Modrak in 2024. 2024 was the busiest year, with 3. Dr. Modrak has published most often in Respir Med Case Rep. Dr. Modrak's most frequent co-authors are Margaret Rose Connolly, MD, Tetsuro Maeda, MD and Irene B. Perillo, MD.

CMS Open Payments shows 2 general payments to Dr. Modrak from 2 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 68% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $125.